These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. State of the art in hereditary muscle channelopathies. Jurkat-Rott K; Lehmann-Horn F Acta Myol; 2010 Oct; 29(2):343-50. PubMed ID: 21314017 [TBL] [Abstract][Full Text] [Related]
11. New Challenges Resulting From the Loss of Function of Na Nicole S; Lory P Front Pharmacol; 2021; 12():751095. PubMed ID: 34671263 [TBL] [Abstract][Full Text] [Related]
12. Guidelines on clinical presentation and management of nondystrophic myotonias. Stunnenberg BC; LoRusso S; Arnold WD; Barohn RJ; Cannon SC; Fontaine B; Griggs RC; Hanna MG; Matthews E; Meola G; Sansone VA; Trivedi JR; van Engelen BGM; Vicart S; Statland JM Muscle Nerve; 2020 Oct; 62(4):430-444. PubMed ID: 32270509 [TBL] [Abstract][Full Text] [Related]
14. Sodium channelopathies of skeletal muscle result from gain or loss of function. Jurkat-Rott K; Holzherr B; Fauler M; Lehmann-Horn F Pflugers Arch; 2010 Jul; 460(2):239-48. PubMed ID: 20237798 [TBL] [Abstract][Full Text] [Related]